2018 AAO Retina Subday: Special Lecture on Google's Artificial Intelligence for Retina
Karen Jeng-Miller, MD, MPH Ophthalmology Resident Mass Eye & Ear This year, the 2018 Charles L. Schepens Lectureship was awarded to Dr. Paul Sternberg, G.W. Hale Professor and Chair of Vanderbilt Eye Institute, and past president of the American Academy of Ophthalmology. Dr. Emily Chew began with an introduction to Dr. Sternberg, starting with his time at Wilmer (highlighting his musical theater skills!), to his lifelong dedication as an academician, researcher, and leader in the vitreoretinal field, and ending with his devotion as a family man to his wife and children, and friend and colleague to all members of the medical community. As Dr. Sternberg began to speak, he framed his lecture around the following main theme: How do we help the large number of patients who aren’t responding to treatments that we have developed? Up to fifty percent of blindness in the United States continues to be attributed to age-related macular degeneration. Due to limited protective treatments in many neuro-degenerative conditions (AREDS in AMD, IOP lowering therapies in glaucoma), vision loss occurs in many cases. Unfortunately, this serves as a major medical problem with large social and economic burdens. As a result, Dr. Sternberg’s lectureship highlighted the role of regenerative medicine in addressing these needs:
- Why regenerative vision and what are the challenges?
- Where do we stand in current clinical care?
- What approaches should we consider?
- How will regenerative medicine transform eye care?